Worasak Kaewkong

Worasak Kaewkong

Auto-generated profile, based on publicly available information

Worasak Kaewkong

Department of Biochemistry, Faculty of Medical Science, Naresuan University, 65000 Phitsanulok, Thailand

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
NYNeil Young
Neil Young
NNNiranjan Nagarajan
Niranjan Nagarajan
SLSuling Joyce Lin
Suling Joyce Lin
PKPasi Korhonen
Pasi Korhonen
AJAaron R. Jex
Aaron R. Jex
RGRobin Gasser
Robin Gasser
Opisthorchiasis is a neglected, tropical disease caused by the carcinogenic Asian liver fluke, Opisthorchis viverrini. This hepatobiliary disease is linked to malignant cancer (cholangiocarcinoma, CCA) and affects millions of people in Asia. No vaccine is available, and only one drug (praziquantel) is used against the parasite. Little is known about O. viverrini biology and the diseases that it causes. Here we characterize the draft genome (634.5 Mb) and transcriptomes of O. viverrini, elucidate how this fluke survives in the hostile environment within the bile duct and show that metabolic pathways in the parasite are highly adapted to a lipid-rich diet from bile and/or cholangiocytes. We also provide additional evidence that O. viverrini and other flukes secrete proteins that directly modulate host cell proliferation. Our molecular resources now underpin profound explorations of opisthorchiasis/CCA and the design of new interventions.

27 March 2023 in Gels
Verified
Journal Article
Open access
PDF file
STSiriporn Taokaew
Siriporn Taokaew
WKWorasak Kaewkong
Worasak Kaewkong
WKWorawut Kriangkrai
Worawut Kriangkrai
Chitosan is a promising naturally derived polysaccharide to be used in hydrogel forms for pharmaceutical and biomedical applications. The multifunctional chitosan-based hydrogels have attractive properties such as the ability to encapsulate, carry, and release the drug, biocompatibility, biodegradability, and non-immunogenicity. In this review, the advanced functions of the chitosan-based hydrogels are summarized, with emphasis on fabrications and resultant properties reported in literature from the recent decade. The recent progress in the applications of drug delivery, tissue engineering, disease treatments, and biosensors are reviewed. Current challenges and future development direction of the chitosan-based hydrogels for pharmaceutical and biomedical applications are prospected.

15 July 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSuphunwadee Sawong
Suphunwadee Sawong
DPDumrongsak Pekthong
Dumrongsak Pekthong
PSPennapha Suknoppakit
Pennapha Suknoppakit
TWThanwarat Winitchaikul
Thanwarat Winitchaikul
WKWorasak Kaewkong
Worasak Kaewkong
PSPiyarat Srisawang
Piyarat Srisawang
Several fractions ofCalotropis giganteaextracts have been proposed to have potential anticancer activity in many cancer models. The present study evaluated the anticancer activity ofC. giganteastem bark extracts in liver cancer HepG2 cells and diethylnitrosamine (DEN)-induced primary liver cancer in rats. The carcinogenesis model induced by DEN administration has been widely used to study pathophysiological features and responses in rats that are comparable to those seen in cancer patients. The dichloromethane (CGDCM), ethyl acetate, and water fractions obtained from partitioning crude ethanolic extract were quantitatively analyzed for several groups of secondary metabolites and calactin contents. A combination ofC. giganteastem bark extracts with doxorubicin (DOX) was assessed in this study to demonstrate the enhanced cytotoxic effect to cancer compared to the single administration. The combination of DOX and CGDCM, which had the most potential cytotoxic effect in HepG2 cells when compared to the other three fractions, significantly increased cytotoxicity through the apoptotic effect with increased caspase-3 expression. This combination treatment also reduced ATP levels, implying a correlation between ATP and apoptosis induction. In a rat model of DEN-induced liver cancer, treatment with DOX,C. giganteaat low (CGDCM-L) and high (CGDCM-H) doses, and DOX + CGDCM-H for 4 weeks decreased the progression of liver cancer by lowering the liver weight/body weight ratio and the occurrence of liver hyperplastic nodules, fibrosis, and proliferative cells. The therapeutic applications lowered TNF-α, IL-6, TGF-β, and α-SMA inflammatory cytokines in a similar way, implying that CGDCM had a curative effect against the inflammation-induced liver carcinogenesis produced by DEN exposure. Furthermore, CGDCM and DOX therapy decreased ATP and fatty acid synthesis in rat liver cancer, which was correlated with apoptosis inhibition. CGDCM reduced cleaved caspase-3 expression in liver cancer rats when used alone or in combination with DOX, implying that apoptosis-inducing hepatic carcinogenesis was suppressed. Our results also verified the low toxicity of CGDCM injection on the internal organs of rats. Thus, this research clearly demonstrated a promising, novel anticancer approach that could be applied in future clinical studies of CGDCM and combination therapy.

29 September 2024 in Frontiers in Bioscience-Scholar
Verified
Journal Article
Open access
PDF file
PCPreenapan Changphasuk
Preenapan Changphasuk
CIChaturong Inpad
Chaturong Inpad
SHSukanya Horpaopan
Sukanya Horpaopan
SKSasiprapa Khunchai
Sasiprapa Khunchai
SPSuchada Phimsen
Suchada Phimsen
WKWorasak Kaewkong
Worasak Kaewkong
Background: Cholangiocarcinoma (CCA) is a malignancy of the bile duct epithelium that is commonly found in the Thai population. CCA has poor prognosis and a low survival rate due to the lack of early diagnosis methods and the limited effectiveness of current treatments. A number of oncogenic spliced-transcripts resulting from mRNA splicing errors have been reported in CCA, and aberrant mRNA splicing is suspected to be a key driver of this cancer type. The hyperphosphorylation of serine/arginine rich-splicing factors (SRSFs) by serine/arginine protein kinases (SRPKs) causes them to translocate to the nucleus where they facilitate gene splicing errors that generate cancer-related mRNA/protein isoforms. Methods: The correlation between SRPK expression and the survival of CCA patients was analyzed using data from The Cancer Genome Atlas (TCGA) dataset. The effect of SRPK inhibitors (SRPIN340 and SPHINX31) on two CCA cell lines (KKU-213A and TFK-1) was also investigated. The induction of cell death was studied by Calcein-AM/PI staining, AnnexinV/7AAD staining, immunofluorescence (IF), and Western blotting (WB). The phosphorylation and nuclear translocation of SRSFs was tracked by WB and IF, and the repair of splicing errors was examined by Reverse Transcription-Polymerase Chain Reaction (RT-PCR). Results: High levels of SRPK1 and SRPK2 transcripts, and in particular SRPK1, correlated with shorter survival in CCA patients. SRPIN340 and SPHINX31 increased the number of dead and apoptotic cells in a dose-dependent manner. CCA also showed diffuse expression of cytoplasmic cytochrome C and upregulation of cleaved caspase-3. Moreover, SRSFs showed low levels of phosphorylation, resulting in the accumulation of cytoplasmic SRSF1. To link these phenotypes with aberrant gene splicing, the apoptosis-associated genes Bridging Integrator 1 (BIN1), Myeloid cell leukemia factor 1 (MCL-1) and B-cell lymphoma 2 (BCL2) were selected for further investigation. Treatment with SRPIN340 and SPHINX31 decreased anti-apoptotic BIN1+12A and increased pro-apoptotic MCL-1S and BCL-xS. Conclusions: The SRPK inhibitors SRPIN340 and SPHINX31 can suppress the phosphorylation of SRSFs and their nuclear translocation, thereby producing BIN1, MCL-1 and BCL2 isoforms that favor apoptosis and facilitate CCA cell death.

31 December 2013 in The Korean Journal of Parasitology
Verified
Journal Article
Open access
PDF file
WKWorasak Kaewkong
Worasak Kaewkong
PIPewpan M. Intapan
Pewpan M. Intapan
OSOranuch Sanpool
Oranuch Sanpool
PJPenchom Janwan
Penchom Janwan
TTTongjit Thanchomnang
Tongjit Thanchomnang
WMWanchai Maleewong
Wanchai Maleewong
Kaewkong W, et al. Korean J Parasitol. 2013 Dec;51(6):689-694. http://dx.doi.org/10.3347/kjp.2013.51.6.689

1 June 2014 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
WKWorasak Kaewkong
Worasak Kaewkong
PIPewpan M. Intapan
Pewpan M. Intapan
OSOranuch Sanpool
Oranuch Sanpool
PJPenchom Janwan
Penchom Janwan
TTTongjit Thanchomnang
Tongjit Thanchomnang
WMWanchai Maleewong
Wanchai Maleewong